Ghent University Academic Bibliography

Journal Article
A1
open access

Quantification of neoantigen-mediated immunoediting in cancer evolution : letter

Arne Claeys (UGent) and Jimmy Van den Eynden (UGent)

(2023) CANCER RESEARCH. 83(6). p.971-972

Journal Article
A1
open access

Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer

Marija Pizurica (UGent) , Maarten Larmuseau (UGent) , Kim Van der Eecken (UGent) , Louise de Schaetzen van Brienen (UGent) , Francisco Carrillo-Perez, Simon Isphording (UGent) , Nicolaas Lumen (UGent) , Jo Van Dorpe (UGent) , Piet Ost (UGent) , Sofie Verbeke (UGent) , et al.

(2023) CANCER RESEARCH. 83(17). p.2970-2984

Add to list

Journal Article
A1
open access

Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages

Aleksandar Murgaski, Mate Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeek, Jiri Keirsse, Eva Hadadi, Jan Brughmans, Sana M. Arnouk, Ahmed E. I. Hamouda, et al.

(2022) CANCER RESEARCH. 82(20). p.3785-3801

Add to list

Miscellaneous

Heterogeneity of CAFfeinated tumors : sweet targeting perspectives

Olivier De Wever (UGent)

(2022) CANCER RESEARCH. 82(4). p.537-538

Add to list

Loss-of-function mutations in TRAF7 and KLF4 cooperatively activate RAS-like GTPase signaling and promote meningioma development

P Najm, P Zhao, M Steklov, RN Sewduth, MF Baietti, S Pandolfi, N Criem, B Lechat, Teresa Maia (UGent) , Delphi Van Haver (UGent) , et al.

(2021) CANCER RESEARCH. 81(16). p.4218-4229

Add to list

The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype

Niels Vandamme (UGent) , Geertrui Denecker (UGent) , Kenneth Bruneel, Gillian Blancke (UGent) , Ozden Akay, Joachim Taminau (UGent) , Jordy De Coninck (UGent) , Eva De Smedt (UGent) , Nicolas Skrypek (UGent) , Wouter Van Loocke (UGent) , et al.

(2020) CANCER RESEARCH. 80(14). p.2983-2995

Add to list

A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors

Juanita S. Lopez, Ross Camidge, Marco Iafolla, Sylvie Rottey (UGent) , Martin Schuler, Matthew Hellmann, Ani Balmanoukian, Luc Dirix, Michael Gordon, Ryan Sullivan, et al.

(2020) CANCER RESEARCH. 80(16).

Add to list

Fatty acid binding protein 7 regulates beige fat-like differentiation of breast cancer cells and thermogenesis

Masahiro Kawashima, Karim Bensaad, Christos Zois, Alessandro Barberis, Esther Bridges, Christoffer Lagerholm, Ruslan Dmitriev (UGent) , Masakazu Toi, Dmitri B. Papkovsky, Francesca Buffa, et al.

(2020) CANCER RESEARCH. 80(16).

Add to list

Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness

Vivek L. Patel, Evan L. Busch, Tara M. Friebel, Angel Cronin, Goska Leslie, Lesley McGuffog, Julian Adlard, Simona Agata, Bjarni A. Agnarsson, Munaza Ahmed, et al.

(2020) CANCER RESEARCH. 80(3). p.624-638

Add to list

Splenic hematopoietic and stromal cells in cancer progression

Jonas Steenbrugge (UGent) , Emiel De Jaeghere (UGent) , Evelyne Meyer (UGent) , Hannelore Denys (UGent) and Olivier De Wever (UGent)

(2020) CANCER RESEARCH. 81(1). p.27-34

Academic Bibliography

Quantification of neoantigen-mediated immunoediting in cancer evolution : letter

Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer

Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages

Heterogeneity of CAFfeinated tumors : sweet targeting perspectives

Loss-of-function mutations in TRAF7 and KLF4 cooperatively activate RAS-like GTPase signaling and promote meningioma development

The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype

A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors

Fatty acid binding protein 7 regulates beige fat-like differentiation of breast cancer cells and thermogenesis

Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness

Splenic hematopoietic and stromal cells in cancer progression

Contents

Support

Contact